The Transplant Diagnostics Market is anticipated to reach USD 2,074.65 million at a 7.80% CAGR between 2018- 2023, as per the recent Market Research Future (MRFR) analysis. Transplant diagnostics, simply put, are clinical diagnostic tools that augment the efficiency of transplantation procedures. 

Various factors are propelling the global transplant diagnostics market growth. According to the recent MRFR report, such factors include technological advances in transplant diagnostics, the rising number of transplant procedures, the increasing burden of infectious diseases, and growing private-public funding for target research activities. Additional factors fuelling the growth of the market include the rising geriatric population, a growing number of stem cell based, solid, and soft tissue transplantation, rising cases of chronic diseases, advances in HLA typing, improving healthcare infrastructure, fall in gene sequencing cost, and rising installation base of NGS and PCR instruments. 

On the contrary, the huge gap between transplantation and organ donation, limited medical reimbursement, the impact of the COVID-19 and soaring cost of NGS & PCR instruments are factors that may limit the global transplant diagnostics market growth over the forecast period. 

Request Sample Copy: https://www.marketresearchfuture.com/sample_request/1324 

Market Segmentation 

The MRFR report offers an inclusive segmental analysis of the global transplant diagnostics market based on product & service, organ type, screening type, application type, and end user. 

By product and service, the global transplant diagnostics market is segmented into software and services, reagents and consumables, and instruments. Of these, reagents and consumables will lead the market over the forecast period. 

By screening type, the global transplant diagnostics market is segmented into post-plant screening and pre-transplant screening. 

Based on organ type, the global transplant diagnostics market is segmented into lungs, heart, liver, pancreas, kidney, and others. 

By application type, the global transport diagnostic market is segmented into diagnostic applications, research applications, and others. Of these, the diagnostic applications will dominate the market over the forecast period. 

By end user, the global transport diagnostic market is segmented into research laboratories and academic institutes, hospitals and transplant centers, commercial service providers, and others. Of these, hospitals and transplant centers will have a major share in the market over the forecast period. 

 Browse Complete Report: https://www.marketresearchfuture.com/reports/transplant-diagnostics-market-1324 

Regional Analysis 

Based on the region, the global transplant diagnostics market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific, & the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period. Growing number of solid organ-based and stem cell transplantation, increasing private-public funding to develop HLA typing technology, and constant fall in the cost of gene sequencing are adding to the global transplant diagnostics market growth in the region. 

The global transplant diagnostics market in the APAC region is predicted to grow at a fast pace over the forecast period. Large patient pool, improving healthcare infrastructure, increasing private and public support for developing human leukocyte antigen typing technologies, & rising focus of life science companies are adding to the transplant diagnostics market growth in the region. 

The global transplant diagnostics market in Europe is predicted to have healthy growth over the forecast period. Growing awareness about advanced transplant procedures, the availability of sophisticated healthcare infrastructure, huge patient pool having terminal diseases, and rising acceptance of innovative & advanced molecular procedures for transplant diagnostics are adding to the market growth in this region. Italy, Germany, Spain, the UK, and France have the maximum share in the market. 

The global transplant diagnostics market in the MEA is predicted to have sound growth over the forecast period. 

Key Players 

Notable players profiled in the global transplant diagnostics market report include Linkage Biosciences (US), Affymetrix, Inc (US), Immucor Transplant Diagnostics, Inc (US), Illumina, Inc. (US), bioMérieux S.A. (France), Omixon Ltd. (UK), GenDx (Netherlands), Immucor, Inc. (US), QIAGEN N.V. (Netherlands), CareDx (US), Abbott Laboratories Inc (US), Becton Dickinson and Company (US), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), and Thermo Fisher Scientific, Inc. (US).